pcos and glp-1 medications are not approved by the Food Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label PCOS Medications: Rare Side Effects

Ghrelin receptor agonists and GH release

Presented for research literature review only Petri KCC et al

(2) This indefinite decrease is known as somatopause and is associated with difficulty losing weight, bone mineral density loss, other age-related changes, and multiple health risks

Visit us at Perfect B, Doral FL, serving Miami, Coral Gables, Brickell, Aventura, and South Florida patients seeking honest, supervised peptide therapy

Semaglutide GLP-1 (Ozempic, Wegovy) and Zepbound ( tirzepatide ) are two of the most discussed medications for weight loss, and many of our patients inquire about their long-term safety